Incheon, South Korea-based Celltrion’s chairman Jung Jin Seo announced at last week’s JP Morgan Healthcare Conference the company’s strategy for the next decade. In particular, he indicated plans to launch a biosimilar every year until 2030. Biosimilars are generic versions…
Who are the 10 Most Innovative Biopharma Companies?
As the annual JP Morgan Healthcare Conference draws to a close, let’s celebrate the remarkable innovation that drives the biopharma industry. Here’s a look at the top 10 companies noted in the BioSpace Ideal Employer 2019 survey for being the…
BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline
Mainz, Germany-based BioNTech announced it was acquiring Cambridge, Massachusetts-based Neon Therapeutics in an all-stock deal valued at about $67 million. Neon’s focus is on neoantigen therapies that have the potential to be both vaccines and T-cell therapeutics. Neoantigens are immune…
Eli Lilly Plans Spending Spree for 2020
Eli Lilly’s senior vice president and chief financial officer Josh Smiley announced plans for the Indianapolis-based pharmaceutical company to spend from $1 billion to $5 billion each quarter this year as it plans to bolster its pipeline. They’ve already gotten…
Novo Nordisk’s Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes Patients
Novo Nordisk’s Ozempic (semaglutide) won approval from the U.S. Food and Drug Administration (FDA) to reduce the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or death in adults with type 2 diabetes and known heart…
Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment
VANCOUVER, British Columbia, Jan. 17, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that it has appointed Novotech as the contract…
Medtronic buys new spinal cord tech to boost pain therapies unit
Dive Brief: Medtronic announced late Wednesday it acquired Stimgenics, a Bloomington, Illinois-based startup that’s developed a novel spinal cord stimulation waveform Medtronic plans to deliver via its Intellis implantable neurostimulator to treat chronic pain. Medtronic expects the deal to be…
JenaValve TAVR tech amid wave to get breakthrough device status from FDA
Dive Brief: FDA has granted breakthrough device designation to a transcatheter aortic valve replacement system in development at JenaValve Technology, the company said Thursday. JenaValve is working to fill an unoccupied niche in the fast-growing TAVR market by winning approval…
Amid Q4 letdown, Boston Scientific targets $1B in structural heart, $2B single-use endoscope market
After reporting a fourth-quarter revenue shortfall due to a slowdown in its cardiac rhythm management division, Boston Scientific on Tuesday said it aims to deliver revenue growth above its medtech peer group over the next three years by reshaping its…
FDA OKs Abbott clinical trial of MitraClip in moderate risk patients
Dive Brief: Abbott announced Monday FDA approved a clinical trial the company hopes will lead to an expansion of MitraClip’s indication to include patients with moderate surgical risk. The transcatheter mitral valve repair device, used to treat primary mitral regurgitation…
